Page last updated: 2024-11-05

2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-5-((phenylamino)carbonyl)-2h-tetrazolium hydroxide and Disease Models, Animal

2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-5-((phenylamino)carbonyl)-2h-tetrazolium hydroxide has been researched along with Disease Models, Animal in 1 studies

2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-5-((phenylamino)carbonyl)-2H-tetrazolium hydroxide: structure given in first source

Disease Models, Animal: Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases.

Research Excerpts

ExcerptRelevanceReference
"Our findings showed that posaconazole could be useful in the treatment of zygomycosis."3.76In vitro and in vivo activities of posaconazole against zygomycetes with various degrees of susceptibility. ( Barchiesi, F; Giannini, D; Orlando, F; Spreghini, E, 2010)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Spreghini, E1
Orlando, F1
Giannini, D1
Barchiesi, F1

Other Studies

1 other study available for 2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-5-((phenylamino)carbonyl)-2h-tetrazolium hydroxide and Disease Models, Animal

ArticleYear
In vitro and in vivo activities of posaconazole against zygomycetes with various degrees of susceptibility.
    The Journal of antimicrobial chemotherapy, 2010, Volume: 65, Issue:10

    Topics: Amphotericin B; Animals; Antifungal Agents; Child; Disease Models, Animal; Humans; Male; Mice; Micro

2010